| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 19 | |
| #2 | EPO (European Patent Office) | 12 | |
| #3 | Canada | 10 | |
| #4 | Australia | 9 | |
| #5 | Japan | 8 | |
| #6 | Hong Kong | 7 | |
| #7 | Israel | 6 | |
| #8 | WIPO (World Intellectual Property Organization) | 6 | |
| #9 | Chile | 4 | |
| #10 | China | 4 | |
| #11 | Republic of Korea | 4 | |
| #12 | New Zealand | 4 | |
| #13 | Brazil | 3 | |
| #14 | Costa Rica | 3 | |
| #15 | Morocco | 3 | |
| #16 | Mexico | 3 | |
| #17 | Peru | 3 | |
| #18 | Colombia | 2 | |
| #19 | Hungary | 2 | |
| #20 | Philippines | 2 | |
| #21 | Serbia | 2 | |
| #22 | Singapore | 2 | |
| #23 | South Africa | 2 | |
| #24 | Dominican Republic | 1 | |
| #25 | Ecuador | 1 | |
| #26 | Montenegro | 1 | |
| #27 | Slovenia | 1 | |
| #28 | Ukraine | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Biotechnology | |
| #4 | Environmental technology | |
| #5 | Foods and drinks |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Heterocyclic compounds | |
| #4 | Special acyclic compounds | |
| #5 | Acyclic or carbocyclic compounds | |
| #6 | Peptides | |
| #7 | Sugars | |
| #8 | Microorganisms | |
| #9 | Climate change adaptation technologies | |
| #10 | Enzymes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Jaipuri Firoz | 90 |
| #2 | Waldo Jesse | 86 |
| #3 | Kumar Sanjeev | 83 |
| #4 | Mautino Mario | 82 |
| #5 | Kesharwani Tanay | 37 |
| #6 | Zhang Xiaoxia | 35 |
| #7 | Potturi Hima | 27 |
| #8 | Zhuang Hong | 26 |
| #9 | Mautino Mario R | 17 |
| #10 | Firoz Jaipuri | 15 |
| Publication | Filing date | Title |
|---|---|---|
| MA43294A1 | 1-methyl-d-tryptophan salts and prodrugs | |
| WO2014197561A1 | Methods of chemosensitization using immunotherapy | |
| EP2996716A2 | Correlates of efficacy relating to tumor vaccines | |
| AU2014235004A1 | Carbohydrate-modified glycoproteins and uses thereof | |
| EP2976332A1 | Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolization. | |
| CN103547579A | Fused imidazole derivatives useful as ido inhibitors | |
| CA2778115A1 | Imidazole derivatives as ido inhibitors | |
| US2009060930A1 | Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes | |
| EP1735429A2 | Methods and compositions for obtaining hematopoietic stem cells derived from embryonic stem cells and uses thereof | |
| US2005250107A1 | Selectable gene marker system based on expression of N-acetyllactosaminide 3-α galactosyltransferase |